| P2093 | author name string | Marie-Hélène David-Cordonnier | |
| | Sabine Depauw | |
| | Gaëlle Savreux-Lenglet | |
| P2860 | cites work | Protein recognition of the S23906-1-DNA adduct by nuclear proteins: direct involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) | Q86118864 |
| | Binding and modulation of p53 by p300/CBP coactivators | Q24312018 |
| | Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis | Q24652801 |
| | Binding of the human nucleotide excision repair proteins XPA and XPC/HR23B to the 5R-thymine glycol lesion and structure of the cis-(5R,6S) thymine glycol epimer in the 5'-GTgG-3' sequence: destabilization of two base pairs at the lesion site | Q27658074 |
| | Genome maintenance mechanisms for preventing cancer | Q28131737 |
| | S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component | Q28190509 |
| | GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues | Q28239983 |
| | The birth of chemotherapy at Yale. Bicentennial lecture series: Surgery Grand Round | Q28241501 |
| | GAPDH: a common enzyme with uncommon functions | Q28247287 |
| | Structural analysis of glyceraldehyde-3-phosphate dehydrogenase functional diversity | Q28249264 |
| | A dimer interface mutation in glyceraldehyde-3-phosphate dehydrogenase regulates its binding to AU-rich RNA | Q28252728 |
| | S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding | Q28256078 |
| | The macrophage cell surface glyceraldehyde-3-phosphate dehydrogenase is a novel transferrin receptor | Q28275180 |
| | The expression of glyceraldehyde-3-phosphate dehydrogenase associated cell cycle (GACC) genes correlates with cancer stage and poor survival in patients with solid tumors | Q28289698 |
| | The diverse functions of GAPDH: views from different subcellular compartments | Q28291106 |
| | GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation | Q28570143 |
| | DNA repair pathways as targets for cancer therapy | Q29615572 |
| | LEF-1 recognition of platinated GG sequences within double-stranded DNA. Influence of flanking bases. | Q38297031 |
| | High mobility group 1 and 2 proteins bind preferentially to DNA that contains bulky adducts induced by benzo[a]pyrene diol epoxide and N-acetoxy-acetylaminofluorene. | Q38309426 |
| | DNA sequence context modulates the impact of a cisplatin 1,2-d(GpG) intrastrand cross-link on the conformational and thermodynamic properties of duplex DNA. | Q38314491 |
| | A pyrazolato-bridged dinuclear platinum(II) complex induces only minor distortions upon DNA-binding | Q38315298 |
| | Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding | Q38323567 |
| | Covalent binding of antitumor benzoacronycines to double-stranded DNA induces helix opening and the formation of single-stranded DNA: unique consequences of a novel DNA-bonding mechanism. | Q38331782 |
| | DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II). | Q38333904 |
| | DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata | Q38352293 |
| | Binding discrimination of MutS to a set of lesions and compound lesions (base damage and mismatch) reveals its potential role as a cisplatin-damaged DNA sensing protein | Q38356417 |
| | Role of base flipping in specific recognition of damaged DNA by repair enzymes. | Q38361321 |
| | Critical protein GAPDH and its regulatory mechanisms in cancer cells | Q38413973 |
| | Disruption of the nuclear p53-GAPDH complex protects against ischemia-induced neuronal damage | Q38755737 |
| | GAPDH binds to active Akt, leading to Bcl-xL increase and escape from caspase-independent cell death. | Q39156134 |
| | UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells. | Q39249828 |
| | Glyceraldehyde-3-phosphate dehydrogenase regulates cyclooxygenase-2 expression by targeting mRNA stability | Q39274062 |
| | CIB1 prevents nuclear GAPDH accumulation and non-apoptotic tumor cell death via AKT and ERK signaling | Q39281845 |
| | Overexpression of glutaredoxin protects cardiomyocytes against nitric oxide-induced apoptosis with suppressing the S-nitrosylation of proteins and nuclear translocation of GAPDH. | Q39305711 |
| | Binding of glyceraldehyde-3-phosphate dehydrogenase to the cis-acting element of structure-anchored repression in ccn2 mRNA. | Q39607818 |
| | Influence of the stereoisomeric position of the reactive acetate groups of the benzo[b]acronycine derivative S23906-1 on its DNA alkylation, helix-opening, cytotoxic, and antitumor activities | Q39799890 |
| | Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase | Q39879276 |
| | Human glyceraldehyde-3-phosphate dehydrogenase plays a direct role in reactivating oxidized forms of the DNA repair enzyme APE1. | Q39942445 |
| | Glyceraldehyde-3-phosphate dehydrogenase enhances transcriptional activity of androgen receptor in prostate cancer cells | Q40123008 |
| | Effect of N-2-acetylaminofluorene and 2-aminofluorene adducts on DNA binding and synthesis by yeast DNA polymerase eta. | Q40246661 |
| | Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog. | Q40320273 |
| | SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity | Q40514663 |
| | Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase | Q40614792 |
| | A Novel CRM1-mediated Nuclear Export Signal Governs Nuclear Accumulation of Glyceraldehyde-3-phosphate Dehydrogenase following Genotoxic Stress | Q40616428 |
| | A nuclear protein complex containing high mobility group proteins B1 and B2, heat shock cognate protein 70, ERp60, and glyceraldehyde-3-phosphate dehydrogenase is involved in the cytotoxic response to DNA modified by incorporation of anticancer nucl | Q40679002 |
| | Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) interacts with apurinic/apyrimidinic sites in DNA. | Q40704579 |
| | Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione. | Q40737953 |
| | Glyceraldehyde-3-phosphate dehydrogenase associates with actin filaments in serum deprived NIH 3T3 cells only | Q40750901 |
| | Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis. | Q40766489 |
| | Okadaic acid induces transcription of junB through a CCAAT box and NF-Y. | Q40811678 |
| | Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity | Q40819330 |
| | Opposite effects of cell differentiation and apoptosis on Ap3A/Ap4A ratio in human cell cultures | Q41082711 |
| | Loss of DNA mismatch repair in acquired resistance to cisplatin | Q41189901 |
| | Glyceraldehyde-3-phosphate dehydrogenase regulates endothelin-1 expression by a novel, redox-sensitive mechanism involving mRNA stability. | Q41356595 |
| | Evaluation of the cytotoxic mechanisms mediated by the broad-spectrum antitumor alkaloid acronycine and selected semisynthetic derivatives | Q41644833 |
| | Rab2 utilizes glyceraldehyde-3-phosphate dehydrogenase and protein kinase C{iota} to associate with microtubules and to recruit dynein | Q42121385 |
| | Involvement of high mobility group B proteins in cisplatin-induced cytotoxicity in squamous cell carcinoma of skin. | Q42163245 |
| | Is GAPDH a relevant housekeeping gene for normalisation in colorectal cancer experiments? | Q42346264 |
| | S-nitrosylation of B23/nucleophosmin by GAPDH protects cells from the SIAH1-GAPDH death cascade | Q42545938 |
| | Strand opening by the UvrA(2)B complex allows dynamic recognition of DNA damage | Q42680761 |
| | Paraquat exposure induces nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the activation of the nitric oxide-GAPDH-Siah cell death cascade. | Q43061139 |
| | Energetics, conformation, and recognition of DNA duplexes modified by monodentate Ru(II) complexes containing terphenyl arenes | Q43106305 |
| | Biophysical studies on the stability of DNA intrastrand cross-links of transplatin. | Q43222524 |
| | Brostallicin (PNU-166196), a new minor groove DNA binder: preclinical and clinical activity | Q43235606 |
| | An unusual DNA binding compound, S23906, induces mitotic catastrophe in cultured human cells | Q43275764 |
| | New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. | Q30322264 |
| | Evidence for thiol/disulfide exchange reactions between tubulin and glyceraldehyde-3-phosphate dehydrogenase. | Q30370225 |
| | Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases | Q30372906 |
| | Exploring damage recognition models in prokaryotic nucleotide excision repair with a benzo[a]pyrene-derived lesion in UvrB | Q30497240 |
| | Replication protein A (RPA) binding to duplex cisplatin-damaged DNA is mediated through the generation of single-stranded DNA. | Q30631650 |
| | Recognition of nonhybridizing base pairs during nucleotide excision repair of DNA | Q30639682 |
| | The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: implications for recognition and repair of antitumor alkylators. | Q30981252 |
| | Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair. | Q30998417 |
| | Interactions of human replication protein A with single-stranded DNA adducts | Q31111443 |
| | Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein | Q31151074 |
| | A novel protein complex distinct from mismatch repair binds thioguanylated DNA. | Q31843972 |
| | Base selectivity and effects of sequence and DNA secondary structure on the formation of covalent adducts derived from the equine estrogen metabolite 4-hydroxyequilenin. | Q33227572 |
| | Specific and efficient binding of xeroderma pigmentosum complementation group A to double-strand/single-strand DNA junctions with 3'- and/or 5'-ssDNA branches | Q33266920 |
| | Regulation of oncogenic transcription factor hTAF(II)68-TEC activity by human glyceraldehyde-3-phosphate dehydrogenase (GAPDH). | Q33273931 |
| | Recognition of cisplatin-DNA interstrand cross-links by replication protein A. | Q33363632 |
| | Von Hippel-Lindau-coupled and transcription-coupled nucleotide excision repair-dependent degradation of RNA polymerase II in response to trabectedin | Q33377399 |
| | Activation of AMP-activated protein kinase stimulates the nuclear localization of glyceraldehyde 3-phosphate dehydrogenase in human diploid fibroblasts | Q33533561 |
| | Moonlighting proteins. | Q33543960 |
| | Reactions of glyceraldehyde 3-phosphate dehydrogenase sulfhydryl groups with bis-electrophiles produce DNA-protein cross-links but not mutations | Q33726109 |
| | Ataxia telangiectasia mutated- and Rad3-related kinase drives both the early and the late DNA-damage response to the monofunctional antitumour alkylator S23906. | Q33864110 |
| | Novel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatin | Q33994331 |
| | DNA-Destabilizing Agents as an Alternative Approach for Targeting DNA: Mechanisms of Action and Cellular Consequences | Q34042848 |
| | Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration | Q34071097 |
| | Teratogen-Induced Oxidative Stress Targets Glyceraldehyde-3-Phosphate Dehydrogenase in the Organogenesis Stage Mouse Embryo | Q34322036 |
| | The antitumor agent ecteinascidin 743: characterization of its covalent DNA adducts and chemical stability. | Q34476352 |
| | Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA. | Q34505128 |
| | Ecteinascidin-743 inhibits activated but not constitutive transcription. | Q34524124 |
| | Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action | Q34526125 |
| | Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin | Q34570044 |
| | Interaction of TPPP/p25 protein with glyceraldehyde-3-phosphate dehydrogenase and their co-localization in Lewy bodies | Q34572066 |
| | Glyceraldehyde-3-phosphate dehydrogenase interacts with proapoptotic kinase mst1 to promote cardiomyocyte apoptosis | Q34634209 |
| | Sulfur mustard induced nuclear translocation of glyceraldehyde-3-phosphate-dehydrogenase (GAPDH). | Q34799040 |
| | Role of apoptosis signal-regulating kinase 1 (ASK1) as an activator of the GAPDH-Siah1 stress-signaling cascade | Q34801671 |
| | Chemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancer | Q34849073 |
| | Identification of GAPDH as a protein target of the saframycin antiproliferative agents | Q37645294 |
| | Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer. | Q37670414 |
| | On the functional diversity of glyceraldehyde-3-phosphate dehydrogenase: biochemical mechanisms and regulatory control | Q37884659 |
| | Basic biology of GAPDH. | Q38031191 |
| | Compartmentation of GAPDH. | Q38031193 |
| | Novel insight into the role of GAPDH playing in tumor | Q38036608 |
| | Glyceraldehyde-3-phosphate dehydrogenase: a promising target for molecular therapy in hepatocellular carcinoma | Q38042261 |
| | Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target | Q38085071 |
| | Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease | Q38253288 |
| | Protein moonlighting: a new factor in biology and medicine | Q38268466 |
| | Oxidative modifications of glyceraldehyde-3-phosphate dehydrogenase play a key role in its multiple cellular functions | Q43299556 |
| | Synthesis and cytotoxic and antitumor activity of benzo[b]pyrano[3, 2-h]acridin-7-one analogues of acronycine | Q43504763 |
| | Hierarchy of DNA damage recognition in Escherichia coli nucleotide excision repair | Q43547641 |
| | The cost of DNA bending | Q43566240 |
| | Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors. | Q43698960 |
| | Induction of apoptosis in HL-60 leukemia and B16 melanoma cells by the acronycine derivative S23906-1. | Q43984001 |
| | Transcriptional response pathways in a yeast strain sensitive to saframycin a and a more potent analog: evidence for a common basis of activity | Q44006810 |
| | Alkylation of guanine in DNA by S23906-1, a novel potent antitumor compound derived from the plant alkaloid acronycine | Q44082093 |
| | New antitumor agents in the acronycine series | Q44178245 |
| | Lactate dehydrogenase and glyceraldehyde-phosphate dehydrogenase are single-stranded DNA-binding proteins that affect the DNA-polymerase-alpha-primase complex | Q44465149 |
| | Covalent binding to glutathione of the DNA-alkylating antitumor agent, S23906-1. | Q44489242 |
| | Oxidation of glyceraldehyde-3-phosphate dehydrogenase enhances its binding to nucleic acids | Q44533951 |
| | DNA Interactions of Monofunctional Organometallic Ruthenium(II) Antitumor Complexes in Cell-free Media | Q44600759 |
| | Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study | Q44655765 |
| | A transesterification reaction is implicated in the covalent binding of benzo[b]acronycine anticancer agents with DNA and glutathion | Q44707659 |
| | Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes | Q45144293 |
| | Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity. | Q45233943 |
| | Histone 2B (H2B) expression is confined to a proper NAD+/NADH redox status | Q46444370 |
| | Regulation of plant cytosolic glyceraldehyde 3-phosphate dehydrogenase isoforms by thiol modifications | Q46735017 |
| | Equilenin-derived DNA adducts to cytosine in DNA duplexes: structures and thermodynamics | Q46785126 |
| | Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand. | Q46893533 |
| | The evaluation of nitric oxide scavenging activity of certain herbal formulations in vitro: a preliminary study | Q47325343 |
| | Microtubule-associated protein 1B binds glyceraldehyde-3-phosphate dehydrogenase | Q48158887 |
| | Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis | Q48275909 |
| | Glyceraldehyde-3-phosphate dehydrogenase is a nonhistone protein and a possible activator of transcription in neurons | Q48331174 |
| | Cerebral ischemia-reperfusion induces GAPDH S-nitrosylation and nuclear translocation | Q48433772 |
| | Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis | Q48544021 |
| | Analysis of the binding of glyceraldehyde-3-phosphate dehydrogenase to microtubules, the mechanism of bundle formation and the linkage effect | Q48876781 |
| | A history of cancer chemotherapy | Q34869530 |
| | Yeast Tdh3 (glyceraldehyde 3-phosphate dehydrogenase) is a Sir2-interacting factor that regulates transcriptional silencing and rDNA recombination | Q35022326 |
| | Overexpression of FOXO3, MYD88, and GAPDH Identified by Suppression Subtractive Hybridization in Esophageal Cancer Is Associated with Autophagy | Q35094166 |
| | Glyceraldehyde 3-phosphate dehydrogenase-telomere association correlates with redox status in Trypanosoma cruzi | Q35578401 |
| | Akt2 kinase suppresses glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-mediated apoptosis in ovarian cancer cells via phosphorylating GAPDH at threonine 237 and decreasing its nuclear translocation | Q35604944 |
| | Structural insights into the recognition of cisplatin and AAF-dG lesion by Rad14 (XPA) | Q35671448 |
| | Design of novel antitumor DNA alkylating agents: the benzacronycine series | Q35699547 |
| | Sequence preferences of DNA interstrand crosslinking agents: quantitation of interstrand crosslink locations in DNA duplex fragments containing multiple crosslinkable sites | Q35761618 |
| | Exocyclic amino groups of flanking guanines govern sequence-dependent adduct conformations and local structural distortions for minor groove-aligned benzo[a]pyrenyl-guanine lesions in a GG mutation hotspot context | Q35781834 |
| | Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation | Q35802323 |
| | Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743. | Q35802653 |
| | HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease | Q35852579 |
| | Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) induces cancer cell senescence by interacting with telomerase RNA component | Q36170627 |
| | BRCA2 is needed for both repair and cell cycle arrest in mammalian cells exposed to S23906, an anticancer monofunctional DNA binder. | Q36188973 |
| | A mutation in glyceraldehyde 3-phosphate dehydrogenase alters endocytosis in CHO cells | Q36235903 |
| | The efficiencies of damage recognition and excision correlate with duplex destabilization induced by acetylaminofluorene adducts in human nucleotide excision repair | Q36413249 |
| | Nitric oxide-GAPDH-Siah: a novel cell death cascade | Q36457904 |
| | Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene | Q36757653 |
| | The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer | Q36982940 |
| | Deprenyl enhances the teratogenicity of hydroxyurea in organogenesis stage mouse embryos | Q37000036 |
| | Structure and mechanism for DNA lesion recognition | Q37044560 |
| | Siah-1b is a direct transcriptional target of p53: identification of the functional p53 responsive element in the siah-1b promoter | Q37073959 |
| | Poly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes | Q37172217 |
| | Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage | Q37199282 |
| | Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons | Q37368739 |
| | Damage detection and base flipping in direct DNA alkylation repair | Q37369004 |
| | Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines | Q37397248 |
| | Direct binding of glyceraldehyde 3-phosphate dehydrogenase to telomeric DNA protects telomeres against chemotherapy-induced rapid degradation | Q37462845 |
| | Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct | Q37522716 |
| | Dynamic two-stage mechanism of versatile DNA damage recognition by xeroderma pigmentosum group C protein | Q37581154 |
| | A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase | Q37597621 |
| | Novel roles for GAPDH in cell death and carcinogenesis. | Q37603056 |
| | Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities. | Q50914964 |
| | The multifunctional glycolytic protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a novel macrophage lactoferrin receptor. | Q51761328 |
| | Mechanism of interaction of CC-1065 (NSC 298223) with DNA. | Q52504772 |
| | SIRT1 interacts with and protects glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from nuclear translocation: implications for cell survival after irradiation. | Q53157483 |
| | Generation of replication-dependent double-strand breaks by the novel N2-G-alkylator S23906-1. | Q53610678 |
| | Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells. | Q54352470 |
| | Increased DNA Binding Specificity for Antitumor Ecteinascidin 743 through Protein−DNA Interactions? | Q57966463 |
| | DNA interactions of dinuclear RuII arene antitumor complexes in cell-free media | Q60240455 |
| | The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin | Q60322887 |
| | Thermostability of double-stranded deoxyribonucleic acids: effects of covalent additions of a psoralen | Q69685051 |
| | Biosynthesis of the human base excision repair enzyme uracil-DNA glycosylase | Q69686961 |
| | Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase | Q70529043 |
| | Phase I-II evaluation of acronine in patients with multiple myeloma | Q71030334 |
| | The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin | Q71533749 |
| | Uracil DNA-glycosylase/glyceraldehyde-3-phosphate dehydrogenase is an Ap4A binding protein | Q71936198 |
| | A mechlorethamine-induced DNA interstrand cross-link bends duplex DNA | Q72422677 |
| | Alkaloids of Acronychia Baueri Schott I. Isolation of the alkaloids and a study of the antitumor and other biological properties of acronycine | Q72933228 |
| | Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: evidence that GAPDH is upregulated by p53 | Q73107353 |
| | Alkaloids of the Australian Rutaceæ | Q74207386 |
| | DNA bending by the human damage recognition complex XPC-HR23B | Q78840506 |
| | Acronycine epoxide: a new acridone alkaloid from several Sarcomelicope species | Q79694534 |
| | Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum | Q83131463 |
| | In the absence of cellular poly (A) binding protein, the glycolytic enzyme GAPDH translocated to the cell nucleus and activated the GAPDH mediated apoptotic pathway by enhancing acetylation and serine 46 phosphorylation of p53 | Q84026202 |
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | catalysis | Q82264 |
| | DNA-binding protein | Q2252764 |
| | mechanism of action | Q3271540 |
| | DNA adducts | Q4153410 |
| | DNA | Q7430 |
| | organic chemistry | Q11351 |
| P304 | page(s) | 26555-81 | |
| P577 | publication date | 2015-01-01 | |
| | 2015-11-05 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Protein Recognition in Drug-Induced DNA Alkylation: When the Moonlight Protein GAPDH Meets S23906-1/DNA Minor Groove Adducts | |
| P478 | volume | 16 | |